Keywords: سرطان پانکراس پیشرفته; advanced pancreatic cancer; Bayesian network meta-analysis; chemotherapy; cost-effectiveness analysis; economic evaluation; gemcitabine;
مقالات ISI سرطان پانکراس پیشرفته (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان پانکراس پیشرفته; APC; advanced pancreatic cancer; aPTT; activated partial thromboplastin time; CA 19-9; carbohydrate antigen 19-9; HR; hazard ratio; KPS; Karnofsky performance status; LMWH; low molecular weight heparin; OS; overall survival; PC; pancreatic cancer; QoL; qu
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Targeted therapy; Randomized clinical trials; Meta-analysis; Pathway; Pancreatic cancer;
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Palliative chemotherapy; Clinical trial; Tumor microenvironment; Tumor stroma;
Keywords: سرطان پانکراس پیشرفته; Body mass index; obesity; advanced pancreatic cancer; prognosis; survival; chemotherapy
Keywords: سرطان پانکراس پیشرفته; Family caregivers; advanced pancreatic cancer; qualitative research; mixed methods;
Keywords: سرطان پانکراس پیشرفته; Meta-analysis; Advanced pancreatic cancer; Gemcitabine; Combination therapy;
Original ResearchOptimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; FOLFIRINOX; Tumour response; Relative dose intensity; cRDI;
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Folfirinox; Gemcitabine; Second-line chemotherapy;
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
Keywords: سرطان پانکراس پیشرفته; Serum miR-21; Advanced pancreatic cancer; Chemosensitivity; FasLFasL, Fas ligand; PDAC, pancreatic duct adenocarcinoma; TTP, time to progression; OS, overall survival; microRNA, miRNA; qPCR, quantitative real-time PCR; siRNA, small-interfering RNA; 3′UTR,
Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples
Keywords: سرطان پانکراس پیشرفته; TaqMann low-density array; Advanced pancreatic cancer; Pseudotumoural Chronic pancreatitis; Cancer invasion; Fine needle aspiration; PDAC; pancreatic ductal adenocarcinoma; CP; chronic pancreatitis; EUS-FNAB; endoscopic ultrasound-guided fine needle aspir
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Age; Charlson Comorbidity Index; Comorbidity; Erlotinib; Gemcitabine;
Distal Pancreatectomy for Body-Tail Pancreatic Cancer: Is There a Role for Celiac Axis Resection?
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Distal pancreatectomy; Celiac axis resection; Common hepatic artery; Extended resection; Modified Appleby operation;
Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions
Keywords: سرطان پانکراس پیشرفته; Advanced pancreatic cancer; Second-line chemotherapy; Single-agent chemotherapy; Platinum-based combinations; Targeted agents